PHILADELPHIA The University of Pennsylvania Center for Education and Research on Therapeutics (Penn CERT) will receive $4 million over the next four years to continue and expand its work on improving the use of therapies for infections.
The Penn CERT is a collaboration among Penns Center for Clinical Epidemiology and Biostatistics, the Leonard Davis Institute, and the Hospital of the University of Pennsylvania, as well as The Childrens Hospital of Philadelphia.
This award allows us to continue and expand our work in improving the use of antibiotics, incorporating the new tools of health IT, says Penn CERT director Brian Strom, MD, George S. Pepper Professor of Public Health & Preventive Medicine. It is an indication of Penn's national stature in patient safety, especially in the use of drugs.
Penns CERT will concentrate on the:
The Penn award is part of the federal governments $41.6 million expansion of the Agency for Healthcare Research and Quality (AHRQ)s CERT program, which is under the US Department of Health and Human Services.
This expansion allows AHRQ to build a strong evidence base that consumers, clinicians, and others can use to make critical treatment decisions about therapeutic products and interventions, says AHRQ Director Carolyn M. Clancy, MD. The increased number and breadth of expertise in the CERTs will broaden the range of knowledge to help the health care system make measurable improvements in the quality and safety of medications and other treatments and health care.
The CERTs program now consists of a new coordinating center and 14 university-based research centers (http://www.certs.hhs.gov/).
|Contact: Karen Kreeger|
University of Pennsylvania School of Medicine